Girish Venkataraman to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications Girish Venkataraman has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.216
-
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2023 03 28; 7(6):963-970.
Score: 0.133
-
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort. Am J Hematol. 2016 Jun; 91(4):395-9.
Score: 0.083